Earl Stewart Jr., MD, FACP, an internal medicine physician and medical director of health equity at Wellstar Health System, talks about advancing health equity at the ACP Internal Medicine Meeting 2025 in New Orleans.
The approval is for those with metastatic disease or in whom surgical resection is likely to result in severe morbidity, have no satisfactory alternative treatments,…
RPM gets analyzed in a new report by the Peterson Center on Healthcare.
Erin Lexner, PharmD, BCPS, discussed her team’s experience transitioning to outpatient BEAM from inpatient CBV.
Multiple phase 3 clinical trials demonstrated dupilumab’s (Dupixent; Regeneron, Sanofi) effectiveness in reducing hives and itch in patients with chronic spontaneous urticaria compared with placebo.
The IHI/BMJ International Forum unites the quality improvement community to tackle common challenges. Book now – individual & group packages are available.
Perspectives from a medical school dean about an alternative path for budding physicians.
Patients with unresectable or metastatic hepatocellular carcinoma (HCC) receiving this regimen had favorable median overall survival (23.7 months) compared with standard of care (20.6 months).
Introduction Childhood mortality in the emergency setting is disproportionately high in low-income and middle-income countries (LMIC), with limited research dedicated to improving timely interventions, especially…
Moves prompt praise from opponents of high costs of medications, PBMs.
Julia Ziegengeist, PharmD, BCOP offers insights for pharmacists navigating adjuvant and neoadjuvant treatment of breast cancer.
